NL-OMON36463
Completed
Not Applicable
Improving mobility and balance in Parkinson*s disease through circuit class training: Effects on clinical outcomes, posturography and brain connectivity - IMPACT
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Parkinson's disease
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 36
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patient is diagnosed with Parkinson's Disease, stages II\-III on the Hoehn and Yahr scale, and able to participate in all forms of therapy.
- •2\. Patient\*s medication is stable and remains unchanged during the study period.
- •3\. Sufficient cognitive function (Mini Mental State Examination \> 24\)
Exclusion Criteria
- •1\. Presence of (other) neurological, orthopedic, or cardiopulmonary problems that can impair participation.
- •2\. Any conditions that render the patient unable to understand or adhere to the protocol such as cognitive, visual, and/or language problems.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The effects of augmented visual feedback during balance training in Parkinson's diseaseParkinson's DiseaseMovement disordersNervous System DiseasesParkinson diseaseISRCTN47046299VU University Medical Center (Netherlands)36
Not yet recruiting
Not Applicable
Towards a Parkinson-specific gait, balance, and posture rating scale: development and validation testing plan of complementary investigator-rated and patient-reported items.NL-OMON56182Radboud Universitair Medisch Centrum105
Completed
Not Applicable
The Role of Cerebellar Hyperactivity in Parkinson's DiseaseParkinson's DiseaseNCT02349789Hugo W. Moser Research Institute at Kennedy Krieger, Inc.11
Completed
Early Phase 1
Mobilaser Study to Help With People Who Are Having Problems With Their GaitParkinson's DiseaseParkinsonismNCT01581645Mayo Clinic11
Completed
Early Phase 1
Improving Walking Automaticity in Parkinson's Disease: Levodopa or DonepezilParkinson DiseaseNCT03599726Oregon Health and Science University20